Ulrich Kaiser

Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia

N. Schmitz, J. Gerss, T. Brümmendorf, 2016, Leukemia.

Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia

H. Serve, M. Schaich, M. Bornhäuser, 2023, Leukemia.